Cargando…
Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
OBJECTIVE: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. SUBJECTS AND METHODS: Preformulation studies (Fourier transform infrared and differential scanning c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553261/ https://www.ncbi.nlm.nih.gov/pubmed/28929053 http://dx.doi.org/10.4103/jphi.JPHI_26_17 |
_version_ | 1783256601500581888 |
---|---|
author | Rajendran, Swaminathan Kumar, K. Sathesh Ramesh, S. Rao, Suresh Ranga |
author_facet | Rajendran, Swaminathan Kumar, K. Sathesh Ramesh, S. Rao, Suresh Ranga |
author_sort | Rajendran, Swaminathan |
collection | PubMed |
description | OBJECTIVE: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. SUBJECTS AND METHODS: Preformulation studies (Fourier transform infrared and differential scanning calorimetry) to assess the interaction between SMV and MC and PM were performed before gel formulation. Keeping the concentration of SMV at 2.2%, the concentration of PM and MC was altered to formulate in situ thermosensitive gel at 37°C. Rheological studies were carried to analyze the physical property of the various formulations. Drug release profile and stability studies were done for the selected formulation. The in vitro drug release profile was carried out for using open end tube method and ultraviolet spectroscopy. RESULTS: The preformulation studies showed that there is no interaction between the polymer and drug based on the rheological studies of different formulation, the formulation. F8 gels at 37°C and attains a viscosity of 4150 cps. CONCLUSIONS: PM 25% and MC 5% formed an ideal thermosensitive injectable gel at 37°C for subgingival delivery of SMV and also show controlled drug release for the period of 10 days in vitro. |
format | Online Article Text |
id | pubmed-5553261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55532612017-09-19 Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease Rajendran, Swaminathan Kumar, K. Sathesh Ramesh, S. Rao, Suresh Ranga Int J Pharm Investig Original Research Article OBJECTIVE: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. SUBJECTS AND METHODS: Preformulation studies (Fourier transform infrared and differential scanning calorimetry) to assess the interaction between SMV and MC and PM were performed before gel formulation. Keeping the concentration of SMV at 2.2%, the concentration of PM and MC was altered to formulate in situ thermosensitive gel at 37°C. Rheological studies were carried to analyze the physical property of the various formulations. Drug release profile and stability studies were done for the selected formulation. The in vitro drug release profile was carried out for using open end tube method and ultraviolet spectroscopy. RESULTS: The preformulation studies showed that there is no interaction between the polymer and drug based on the rheological studies of different formulation, the formulation. F8 gels at 37°C and attains a viscosity of 4150 cps. CONCLUSIONS: PM 25% and MC 5% formed an ideal thermosensitive injectable gel at 37°C for subgingival delivery of SMV and also show controlled drug release for the period of 10 days in vitro. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5553261/ /pubmed/28929053 http://dx.doi.org/10.4103/jphi.JPHI_26_17 Text en Copyright: © 2017 International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Research Article Rajendran, Swaminathan Kumar, K. Sathesh Ramesh, S. Rao, Suresh Ranga Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
title | Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
title_full | Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
title_fullStr | Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
title_full_unstemmed | Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
title_short | Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
title_sort | thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553261/ https://www.ncbi.nlm.nih.gov/pubmed/28929053 http://dx.doi.org/10.4103/jphi.JPHI_26_17 |
work_keys_str_mv | AT rajendranswaminathan thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease AT kumarksathesh thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease AT rameshs thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease AT raosureshranga thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease |